This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Peritonitis is an inflammation of the peritoneum, the thin membrane that lines the inner wall of the abdomen and covers most of the abdominal organs. It is typically caused by a bacterial or fungal infection and can range from mild to severe. The most common symptoms of peritonitis are abdominal pain and tenderness, nausea, vomiting, fever, and loss of appetite. Severe cases can cause confusion, mental status changes, and shock. The most common cause of peritonitis is a bacterial infection which is usually acquired by the spread of bacteria from another part of the body, such as the appendix, or from an infected wound. The infection can spread to the peritoneum through the bloodstream or directly from the infected area. Other causes of peritonitis include fungal infections, chemical irritation, and physical trauma. Treatment for peritonitis includes antibiotics, pain medications, and, in severe cases, surgery. Antibiotics are the most common treatment and are usually given intravenously. Surgery may be necessary to drain an abscess or to remove infected organs. In severe cases, a procedure known as peritoneal dialysis may be used to remove toxic substances from the body. If left untreated, peritonitis can cause complications including abscesses, sepsis, and perforation of the intestines. It is important to seek medical attention if you are experiencing any of the symptoms of peritonitis. Early diagnosis and treatment can help prevent serious complications and improve outcomes.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States